Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000235

Chief Medical Officer acquired 17,845 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-25 Exercise or conversion : show line 1 in the form +17,845 $0.68 $12,135 136,655 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-25 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −17,845 107,155 D
Loading xslF345X05/wk-form4_1732743876.xml…